# Docebo Inc.: Form 40-F for the period ended Dec 31, 2025

- Company: [Docebo Inc.](/companies/dcbo.md) (CIK 1829959)
- Form: 40-F
- Filed: 2026-02-27
- Accepted by EDGAR: Feb 27, 2026, 06:48 ET
- Period: 2025-12-31
- Accession: 0001628280-26-012566
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829959/000162828026012566/docebo-20251231_d2.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829959/000162828026012566/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | $242.7m | ifrs-full:RevenueFromContractsWithCustomers |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | $47.9m | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2025-01-01 to 2025-12-31 | $194.8m | ifrs-full:GrossProfit |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | $23.2m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | −$13.1m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | $37.5m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | $1.28 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | $1.31 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | $28.2m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2025-01-01 to 2025-12-31 | $981.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2025-12-31 | $74.0m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2025-12-31 | $151.5m | ifrs-full:CurrentAssets |
| Total assets | at 2025-12-31 | $206.6m | ifrs-full:Assets |
| Current liabilities | at 2025-12-31 | $123.8m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2025-12-31 | $132.6m | ifrs-full:Liabilities |
| Shareholders' equity | at 2025-12-31 | $74.1m | ifrs-full:Equity |
| Shares outstanding | at 2025-12-31 | 28,747,289 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829959/000162828026012566/docebo-20251231_d2.htm

Filed Feb 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-012566. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.